Caleco Pharma develops bio-pharmaceutical and consumer health products, leveraging proprietary “Liver Health” formulations of natural, plant-based (Lamiridosin) extracts to simultaneously pursue a dual pathway model for OTC and prescription commercialization.
The Lamiridosin Franchise consists of the wide range of other products, from nutraceuticals and oral supplements that promote liver health or boost the immune system, to a bevy of dermatological and topical hair care products for the skin and scalp.
Partnerships with Madrid-based Natac Biotech (plant extracts/probiotics), the Universidad Autónoma de Madrid (30 scientists/research facilities), and Rearden Health Partners (product development consultancy) give Caleco Pharma the kind of logistical network needed to maximize product commercialization, both near-term OTC and long-term prescription.
About QualityStocks:
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://Gotstocks.QualityStocks.net
Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment